Prevention of intrathecal baclofen withdrawal syndrome: successful use of a temporary intrathecal catheter.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19920430.
- Also identified by DOI 10.1097/AAP.0b013e3181b4cc6b.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Abrupt cessation of intrathecal baclofen (ITB) administration can cause a life-threatening withdrawal syndrome that requires prompt diagnosis and urgent treatment. The current therapy for this condition is administration of propofol, benzodiazepines, paralytics and supportive care. This study reports a 53-year-old patient with paraplegia with an ITB infusion who presented with an infected pump site. The pump and the catheter were surgically removed and replaced with a temporary externalized intrathecal catheter. The ITB infusion was tapered and simultaneously substituted with progressively higher doses of oral antispasmotics. With this strategy, we were able to avoid life-threatening complications.
Medical subject headings
- Baclofen
- Catheter-Related Infections
- Catheters, Indwelling
- Muscle Relaxants, Central
- Paraplegia
- Spinal Cord Injuries
- Substance Withdrawal Syndrome